Authors
Latest:
Cognitive Aging Research Program Reveals Insights Based on 25 Years of DataA 25-year study of the Lothian Birth Cohorts found that childhood intelligence, lifestyle factors, and brain health significantly impact cognitive aging and longevity.
Latest:
Primary Care Clinicians Diagnose Nearly Half of Youth MDD, Report Reveals, Often During a CrisisYouth depression is often diagnosed during crisis events, underscoring the need for primary care education and enhanced collaborative care resources.
Latest:
Closing Thoughts on the Treatment of MDDRoger S. McIntyre, MD, FRCPC, and Carmen Kosicek, MSN, PMHNP-BC, discuss the future of MDD treatment and share closing thoughts.
Latest:
Vaccination Strategies Practice Pearls And Key Take AwaysDrs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.
Latest:
Impact of Pain on Daily Life Greater Threat to Mental Health than Pain Intensity, Study FindsMental wellbeing for some persons with chronic pain appears to be associated with the flexibility to adjust goals and persevere despite obstacles, setbacks, note study authors.
Latest:
Long COVID: Hyperbaric Oxygen Therapy Offers Hope for Understanding and Treating SymptomsHyperbaric oxygen therapy in a randomized placebo-controlled trial resulted in improved global cognitive function, energy, sleep, and pain interference in long COVID patients.
Latest:
Vaccination Strategies Practice Pearls And Key Take AwaysDrs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.
Latest:
COPD Increases Risk for Heart Failure in People who Experience AMI“Patients with COPD who have AMI are less aggressively treated than those without COPD," leading to higher in-hospital mortality and long-term mortality,” wrote authors.
Latest:
With the Flu Season in Overdrive, Hospitals are OverwhelmedSome hospitals have EDs filled with patients and a number of states are reporting the 2024-2025 version of a COVID-19, flu, and RSV tripledemic.
Latest:
Obesity-related Comorbidities and Treatment: An OverviewAn overview of common and uncommon obesity-related comorbidities and treatment strategies, here.
Latest:
3 Ways Physicians Can Support Patients with Obesity in 2023Three tips on how to support patients on their weight management journey this year.
Latest:
Obesity and Depression in Adolescents: Understanding the InterplayUnderstanding the interplay between obesity and depression in children is key for clinicians to best advise this patient population. An overview, here.
Latest:
Long Colds: How to Manage Patient Expectation About Duration of the Common ColdPatients largely underestimate how long a cold should last and the lingering symptoms too often prompt a request for antibiotics. Primary care, please resist!
Latest:
Final Thoughts on Strategies for Managing and Monitoring Patients Receiving TeplizumabThe panel concludes its discussion with key takeaways on the optimal care of patients with type 1 diabetes care and thoughts on unmet needs within the treatment space.
Latest:
Symbravo Mechanism of Action and Patient Selection, with PI Stewart Tepper, MDTepper, principal investigator for phase 3 trials of Symbravo as acute treatment for migraine in adults, reviews the new drug's dual MOA and target patient populations.
Latest:
For Unknown Causes of Kidney Disease, Genetic Testing Holds PromiseA recent American Kidney Fund survey of 300 primary care and specialty clinicians found ~15% of their patients had kidney disease of unknown origin.
Latest:
Investigational Oral Agent Muvalaplin Reduces Lp(a) by Up to 85% in High-Risk Adults: Phase 2 DataLp(a) is a genetically-driven and independent risk factor for CVD with no approved treatments. Lilly is advancing muvalaplin and has some good competition.
Latest:
5 Elemental Facts About Electronic Cigarettes All Clinicians Should KnowThe 5 summaries that follow cover harmful ingredients, associated health risks, industry marketing tactics, and current regulatory efforts.
Latest:
When the Patient Says Pain is the Problem, Physiatry Has a PlanThe goal of a PM&R physician is to identify the source of function-limiting pain and then develop the best plan for each patient to return them to their lives.
Latest:
Guidance for PCPs: Streamlining Menopause CarePanelists discuss strategies for simplifying complex information for primary care physicians (PCPs), provide tips on how PCPs can effectively communicate evidence-based treatment options to patients, and outline actionable points and key takeaways to enhance patient care in managing menopause symptoms.
Latest:
Key Insights and Final Thoughts on Screening and Management of T1DPanelists discuss key insights on the importance of early screening for T1D, the role of antibody testing in identifying at-risk individuals, and the need for timely intervention to preserve ß-cell function and optimize long-term management strategies for better patient outcomes.
Latest:
Final Thoughts on Identifying and Managing Patients with T1DPanelists discuss how early identification of Type 1 diabetes through screening programs, combined with emerging therapies like teplizumab, offers new opportunities for intervention and improved patient outcomes in at-risk populations.
Latest:
Mifepristone Future Uncertain, Pushback is United and SwiftThe FDA, women's health groups and professional societies, and state governors are all pushing back against the April 7 ruling by Texas District Judge Matthew Kacsmaryk.
Latest:
Axsome Therapeutics: FDA Accepts NDA Resubmission for AXS-07 for Acute Treatment of MigraineBased on its acceptance of the resubmission, FDA has assigned a PDUFA action goal date of January 31, 2025 for AXS-07.
Latest:
Stress Management 2021: The Case for Self-Care in the COVID-19 EraObesity Medicine Association President Craig Primack, MD, reminds PCPs that stress management is a key to good self care for everyone and offers tips to share with patients.
Latest:
Dupilumab Reduces COPD Exacerbations for Patient with T2 Inflammation in Landmark Phase 3 TrialFindings of the BOREAS trial of patients with COPD and type 2 inflammation make dupilumab the first biologic to significantly reduce exacerbations by 30% vs placebo.
Latest:
GoodRx, Opill Team Up on OTC Delivery Program for ContraceptiveThe new e-commerce partnership expands access to Opill by allowing direct delivery of the contraceptive to consumers' homes without a prescription.
Latest:
WHO Recommends Flu Vaccine Composition for 2025-26 Northern Hemisphere Season as US HHS Cancels ACIP, VRBAC MeetingsTwo official US vaccine planning meetings cancelled in February is an "unprecedented situation," said NFID medical director Robert Hopkins, Jr, MD.
